The Tasmanian Devil and DFTD
Transcriptome and proteome profiling reveals stress induced expression signatures of imiquimod treated Tasmanian devil facial tumor disease (DFTD) cells
20
Population and disease modelling in the Tasmanian devil
114
Immune recognition of devil facial tumour disease by the Tasmanian devil
221
To what extent do we understand DFTD, and what are the conservation options for Tasmanian Devils?
38
Toll like receptors in the endangered Tasmanian devil and devil facial tumour disease
314
The devil is in the details: Genomics of transmissible cancers in Tasmanian devils
8
Spatial analysis of Tasmanian Devil facial tumour disease
62
The ERBB STAT3 Axis Drives Tasmanian Devil Facial Tumor Disease
25
An investigation into factors affecting breeding success in the Tasmanian devil (Sarcophilus harrisii)
296
Tasman PCR: A genetic diagnostic assay for Tasmanian devil facial tumour diseases
10
Biomarker discovery for pre clinical diagnosis of Tasmanian devil facial tumour disease
201
Regression of devil facial tumour disease following immunotherapy in immunised Tasmanian devils
14
Manipulating the immune response of Tasmanian Devils to target Devil Facial Tumour Disease
244
Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour disease
22
Untangling the model muddle: Empirical tumour growth in Tasmanian devil facial tumour disease
7
The diet of the Tasmanian Devil, Sarcophilus harrisii, as determined from analysis of scat and stomach contents
11
Immunization strategies producing a humoral IgG immune response against devil facial tumor disease in the majority of Tasmanian devils destined for wild release
12
The Tasmanian devil microbiome—implications for conservation and management
11
Social organisation and behaviour of the Tasmanian devil, Sarcophilus harrisii
13
Social organisation and behaviour of the Tasmanian devil, Sarcophilus harrisii
272